课题基金 / 基金详情

Do H3K4 methyltransferases MLL4 and MLL3 instruct the mammalian body plan?

Do H3K4 methyltransferases MLL4 and MLL3 instruct the mammalian body plan?
H3K4 甲基转移酶 MLL4 和 MLL3 是否指导哺乳动物的身体规划?
批准号:
426821658
负责人:
Dr. Andrea Kranz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Dr. Andrea Kranz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The major epigenetic regulator, MLL4, is prominently mutated in many cancers and is one of six mammalian histone 3 lysine 4 (H3K4) methyltransferases. Heterozygous mutations of MLL4 provoke Kabuki syndrome, which involves mental retardation, facial and other morphological changes, and metabolic disorders. Despite its medical importance, the role of MLL4 in mouse development has only been partially examined. We have been systematically documenting the embryonic roles of all six H3K4 methyltransferases and report that Mll4 null embryos undergo defective gastrulation owing to a defect in establishing the anterior visceral endoderm (AVE) and consequently, the anterior-posterior (A-P) axis during early development. To probe later into development, we generated a new loxP conditional Mll4 allele. Using Sox2Cre, we identified a role for MLL4 in the epiblast and using R26CreERT2 with tamoxifen-induction at different times, found evidence for MLL4 contribution until the completion of A-P axis elongation at E13.5. We propose that MLL4 is continuously required for neuromesodermal progenitor (NMP) specification of trunk elongation, segmentation and the tail, potentially exerted through regulation of Hox cluster colinearity. Conditional mutagenesis also revealed that MLL3, which is not required until birth, can substitute for MLL4 during the elongation of the A-P axis. Using conditional mutagenesis in utero and in embryonic stem cell lines (ESCs) established from our conditional knockout mouse lines, we aim to dissect the contributions of MLL4 (and MLL3) to the establishment of the mammalian body plan. We will investigate whether embryonic development can be recapitulated in vitro through NMPs and gastruloids in the absence of MLL4 (+/-MLL3) with a focus on colinear induction of Hox cluster expression. These analyses include a structure/function dissection of MLL4 using a deletion series of Mll4 BAC transposons introduced into the conditional Mll4 ESCs. Using in situ hybridization, imaging techniques, and conditional mutagenesis methods developed in part by our lab, together with expression profiling, deep sequencing and in vitro embryogenesis, we aim to identify the relationship between MLL4 (and MLL3) in specification of the mammalian body plan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional examination of H3K4 methyltransferases in myeloid neoplasia
  • 批准号:
    247996654
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Dr. Andrea Kranz
  • 依托单位:
Die Entwicklung des vaskulären und neuronalen Systems nach konditionaler Deletion der Rezeptortyrosinkinase Flk1
  • 批准号:
    5382573
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $0.0万
  • 财政年份:
    2002
  • 负责人:
    Dr. Andrea Kranz
  • 依托单位:
国内基金
海外基金
组蛋白H3K4甲基化招募Lid2复合体维持转录稳态和细胞身 份的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
  • 批准号:
    82300769
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    张晓琴
  • 依托单位:
H3K4高乙酰化促进SLIT2基因转录延缓母猪初情启动的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    周小枫
  • 依托单位:
PHIP识别甲基化组蛋白H3K4的分子机制研究及特异性拮抗剂的发现
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    刘艳丽
  • 依托单位: